NATURE'S FIRST RESPONDER
LIVE

Serial Number

87824141

Owner

NantKwest, Inc.

Attorney

Alicia M. Passerin

First Use Date

Feb 26, 2018

Filing Date

Mar 7, 2018

Add to watchlist:

No watchlists yet
View on USPTO

NATURE'S FIRST RESPONDER Trademark

Serial Number: 87824141 • Registration: 6059246

NATURE'S FIRST RESPONDER is a trademark filed by NantKwest, Inc. on March 7, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NantKwest, Inc.

Culver City, CA 90232

Entity Type: 03

IMMUNITYBIO, INC. (143 trademarks)

3530 JOHN HOPKINS COURT
SAN DIEGO, CA 92121

Entity Type: 03

Trademark Details

Filing Date

March 7, 2018

Registration Date

May 19, 2020

First Use Anywhere

February 26, 2018

First Use in Commerce

February 26, 2018

Published for Opposition

July 24, 2018

Goods & Services

Cells for scientific, laboratory, medical, clinical, therapeutic, and diagnostic research; cell-derived preparations, namely, natural killer cell-derived preparations, for scientific, laboratory, medical, clinical, therapeutic, and diagnostic research; kits comprised of cells, reagents and related instructions, for clinical, medicinal, and therapeutic research purposes; kits comprised of cell-derived preparations, namely, natural killer cell-derived preparations, reagents and related instructions, for clinical, medicinal, and therapeutic research purposes

Cells for clinical, medical, and therapeutic purposes; cell-derived preparations, namely, natural killer cell-derived preparations, for clinical, medical, and therapeutic purposes; therapeutic products derived from cells, namely, natural killer cells, for clinical, medical, and therapeutic purposes; therapeutic products derived from cell-derived preparations, namely, natural killer cell-derived preparations, for clinical, medical, and therapeutic purposes; kits comprised of cells, reagents and related instructions, for clinical, medicinal, and therapeutic purposes; kits comprised of cell-derived preparations, namely, natural killer cell-derived preparations, reagents and related instructions, for clinical, medicinal, and therapeutic purposes

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Aug 13, 2026 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Aug 13, 2026 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 13, 2026 APRE
TEAS SECTION 8 & 15 RECEIVED
May 8, 2026 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 19, 2025 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 9, 2021 ASGN
REGISTERED-PRINCIPAL REGISTER
May 19, 2020 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 14, 2020 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 11, 2020 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 9, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 9, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 9, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 16, 2019 GNRN
NON-FINAL ACTION E-MAILED
Oct 16, 2019 GNRT
SU - NON-FINAL ACTION - WRITTEN
Oct 16, 2019 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 24, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 24, 2019 CRFA
ASSIGNED TO LIE
Sep 24, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 17, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 27, 2019 GNRN
NON-FINAL ACTION E-MAILED
Mar 27, 2019 GNRT
SU - NON-FINAL ACTION - WRITTEN
Mar 27, 2019 CNRT
ASSIGNED TO EXAMINER
Mar 26, 2019 DOCK
STATEMENT OF USE PROCESSING COMPLETE
Mar 9, 2019 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 9, 2019 AITU
USE AMENDMENT FILED
Feb 15, 2019 IUAF
TEAS STATEMENT OF USE RECEIVED
Feb 15, 2019 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 18, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 24, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jul 24, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 4, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 20, 2018 CNSA
ASSIGNED TO EXAMINER
Jun 19, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 14, 2018 NWOS
NEW APPLICATION ENTERED
Mar 10, 2018 NWAP